{"entity":{"type":"insider","cik":"0001803773","url":"/insider/0001803773","json_url":"/insider/0001803773.json","name":"Winslow Garrett","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":7,"first":"2020-11-23","last":"2026-07-07","span_basis":"filed_date"},"name_variants":[{"name":"Winslow Garrett","source":"filing","n_filings":7,"first_seen":"2020-11-23","last_seen":"2026-07-07"}],"transactions":[{"id":6178270,"accession":"0001193125-26-297818","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-297818","line_url":"/filing/0001193125-26-297818#line-2","is_derivative":false,"issuer_cik":"0001800315","issuer_name":"Damora Therapeutics, Inc.","issuer_ticker":"DMRA","issuer_name_source":null,"issuer_url":"/issuer/0001800315","owner_cik":"0001803773","owner_name":"Winslow Garrett","owner_display_name":"Winslow Garrett","owner_url":"/insider/0001803773","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":245.0,"shares_display":"245","price_per_share":29.98,"price_display":"29.98","price_state":"stated","total_value":7345.1,"total_display":"7,345.10","total_whole":"7,345","shares_owned_after":2289.0,"shares_owned_after_display":"2,289","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-06","filed_date":"2026-07-07","scope":"insider"},{"id":6170353,"accession":"0001193125-26-004568","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-004568","line_url":"/filing/0001193125-26-004568#line-2","is_derivative":false,"issuer_cik":"0001800315","issuer_name":"Galecto, Inc.","issuer_ticker":"GLTO","issuer_name_source":null,"issuer_url":"/issuer/0001800315","owner_cik":"0001803773","owner_name":"Winslow Garrett","owner_display_name":"Winslow Garrett","owner_url":"/insider/0001803773","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":255.0,"shares_display":"255","price_per_share":21.38,"price_display":"21.38","price_state":"stated","total_value":5451.9,"total_display":"5,451.90","total_whole":"5,452","shares_owned_after":1854.0,"shares_owned_after_display":"1,854","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-02","filed_date":"2026-01-06","scope":"insider"},{"id":4132831,"accession":"0000950170-25-094575","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-094575","line_url":"/filing/0000950170-25-094575#line-2","is_derivative":false,"issuer_cik":"0001800315","issuer_name":"Galecto, Inc.","issuer_ticker":"GLTO","issuer_name_source":null,"issuer_url":"/issuer/0001800315","owner_cik":"0001803773","owner_name":"Winslow Garrett","owner_display_name":"Winslow Garrett","owner_url":"/insider/0001803773","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":260.0,"shares_display":"260","price_per_share":3.39,"price_display":"3.39","price_state":"stated","total_value":881.4,"total_display":"881.40","total_whole":"881","shares_owned_after":1429.0,"shares_owned_after_display":"1,429","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-03","filed_date":"2025-07-08","scope":"insider"},{"id":4130074,"accession":"0000950170-25-002814","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-002814","line_url":"/filing/0000950170-25-002814#line-2","is_derivative":false,"issuer_cik":"0001800315","issuer_name":"Galecto, Inc.","issuer_ticker":"GLTO","issuer_name_source":null,"issuer_url":"/issuer/0001800315","owner_cik":"0001803773","owner_name":"Winslow Garrett","owner_display_name":"Winslow Garrett","owner_url":"/insider/0001803773","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":471.0,"shares_display":"471","price_per_share":5.6,"price_display":"5.60","price_state":"stated","total_value":2637.6,"total_display":"2,637.60","total_whole":"2,638","shares_owned_after":1009.0,"shares_owned_after_display":"1,009","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-03","filed_date":"2025-01-07","scope":"insider"},{"id":4387150,"accession":"0001209191-21-068028","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-068028","line_url":"/filing/0001209191-21-068028#line-1","is_derivative":false,"issuer_cik":"0001800315","issuer_name":"Galecto, Inc.","issuer_ticker":"GLTO","issuer_name_source":null,"issuer_url":"/issuer/0001800315","owner_cik":"0001803773","owner_name":"Winslow Garrett","owner_display_name":"Winslow Garrett","owner_url":"/insider/0001803773","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":2.48,"price_display":"2.48","price_state":"stated","total_value":4960.0,"total_display":"4,960.00","total_whole":"4,960","shares_owned_after":4000.0,"shares_owned_after_display":"4,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-03","filed_date":"2021-12-06","scope":"insider"},{"id":4999056,"accession":"0001209191-21-042718","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-042718","line_url":"/filing/0001209191-21-042718#line-1","is_derivative":false,"issuer_cik":"0001800315","issuer_name":"Galecto, Inc.","issuer_ticker":"GLTO","issuer_name_source":null,"issuer_url":"/issuer/0001800315","owner_cik":"0001803773","owner_name":"Winslow Garrett","owner_display_name":"Winslow Garrett","owner_url":"/insider/0001803773","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":4.8,"price_display":"4.80","price_state":"stated","total_value":9600.0,"total_display":"9,600.00","total_whole":"9,600","shares_owned_after":2000.0,"shares_owned_after_display":"2,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-23","filed_date":"2021-06-23","scope":"insider"},{"id":2785673,"accession":"0000905718-20-001132","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000905718-20-001132","line_url":"/filing/0000905718-20-001132#line-3","is_derivative":false,"issuer_cik":"0001566373","issuer_name":"F-star Therapeutics, Inc.","issuer_ticker":"SBPH","issuer_name_source":null,"issuer_url":"/issuer/0001566373","owner_cik":"0001803773","owner_name":"Winslow Garrett","owner_display_name":"Winslow Garrett","owner_url":"/insider/0001803773","role":"Officer (General Counsel and Secretary)","role_mark":"O","role_mark_label":"Officer (General Counsel and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":175.0,"shares_display":"175","price_per_share":4.76,"price_display":"4.76","price_state":"stated","total_value":833.0,"total_display":"833.00","total_whole":"833","shares_owned_after":18575.0,"shares_owned_after_display":"18,575","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-20","filed_date":"2020-11-23","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":7,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":5,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":7},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001800315","name":"Damora Therapeutics, Inc.","url":"/issuer/0001800315","role":"Officer (General Counsel)","n_filings":6,"first_seen":"2021-06-23","last_seen":"2026-07-07"},{"type":"issuer","type_label":"ISSUER","cik":"0001566373","name":"F-star Therapeutics, Inc.","url":"/issuer/0001566373","role":"Officer (General Counsel and Secretary)","n_filings":1,"first_seen":"2020-11-23","last_seen":"2020-11-23"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001803773","retrieved_at":"2026-08-25T13:55:50+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}